Plasma levels of Th1/Th2 type cytokine are associated with change of prolactin and GH/IGF-1 in hemodialysis patients

International Journal of Artificial Organs

Volumn 31, Issue 4, 2008, Pages 303-308

  Liu, Mao Lin ^a   Xu, G ^a   Xue, S R ^a   Zhong, X C ^a   Chen, G X ^a   Chen, Z J ^a  

^a HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

GH IGF I axis; Hemodialysis; Immuno response; Prolactin; Th1 Th2 cytokines

Indexed keywords

BODY FLUIDS; ENDOCRINOLOGY; HEMODIALYZERS; HORMONES; IMMUNE SYSTEM; T-CELLS;

CYTOKINES; GROWTH HORMONE/INSULIN-LIKE GROWTH FACTOR-I AXIS; GROWTH HORMONES; HAEMODIALYSIS; HEMODIALYSIS PATIENT; IMMUNO RESPONSE; INSULIN-LIKE GROWTH FACTOR-I; PROLACTIN; TH1/TH2 CYTOKINE; TH2 CYTOKINE;

DIALYSIS;

CYTOKINE; GAMMA INTERFERON; GROWTH HORMONE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; PROLACTIN; SOMATOMEDIN C; T HELPER TYPE 1 CYTOKINE; T HELPER TYPE 2 CYTOKINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ENDOCRINE DISEASE; FEMALE; GROWTH HORMONE BLOOD LEVEL; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; MALE; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TH1 CELL; TH2 CELL;

EID: 45949097477     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803100405     Document Type: Article

References (38)

1. Goldblum SE, Reed WP, Host defences and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980; 93: 597-13.
2. Mege JL, Capo C, Purgus R, Olmer M. Monocyte production of transforming growth factor β in long-term hemodialysis: Modulation by hemodialysis memhrances. Am J Kidney Dis 1996; 28: 395-9.
3. Kohler H, Arnold W, Renschin G, Dormeyer HH, Meyer zum Buschenfelde KH. Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 1984; 25: 124-8.
4. Beaurain G, Naret C, Marcon L, Grateau G, Drueke T, Urena P, Nelson DL, Bach JF, Chatenoud L. In vivo T cell preactivation in chronic uremic hemodialyzed patients and non-hemodialyzed patients. Kidney Int: 1989; 36: 636-44.
5. Cohen G, Haag-Weber M, HörI WH. Immune dysfunction in uremia. Kidney Int 1997; 52 (Suppl 62): S79-82.
6. Descamps-Latscha B. The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 1993; 2: 883-91.
7. Descamps-Latscha B, Herbelin A, Thu Nguyen A, Roux-Lombard P Zingraff J, Moynot A, Verger CH, Dahmane D, de Groote D, Jungers P, Dayer J-M. Balance between IL-1β, TNF-α, and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 1995; 154: 882-92.
8. Descamps-Latscha B, Jungers P. New molecular aspects of chronic uraemia and dialysis-related immunocompetent cell activation. Nephrol Dial Transplant 1996; 11(Suppl 2): S121-4.
9. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches. Annu Rev Immunol 1997; 15:297-322.
10. Dimitrov S, Lange T, Fehm HL, Born J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav Immun 2004; 18: 368-74.
11. Geffner M. Effects of growth hormone and insulin-like growth factor I on T-and B-lymphocytes and immune function. Acta Paediatr 1997; 423 (Suppl): S76-9.
12. Mustafa A, Nyberg F, Mustafa M, Bakhret M, Mustafa E, Wrnblad B, Adem A. Growth hormone stimulates production of interferon-gamma by human peripheral mononuclear cells. Horm Res 1997; 48: 11-5.
13. Descamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, Chatenoud L. Immune system dysregulation in uremia. Semin Nephrol 1994; 14: 253-60.
14. Daichou Y, Kurashige S, Hashimoto S, Suzuki S. Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients. Nephron 1999; 83: 237-45.
15. Powrie F, Coffman RL. Cytokine regulation of T-cell function: Potential for therapeutic intervention. Immunol Today 1993; 14: 270-4.
16. Mosmann TR, Coffman RL. Th1 and Th2 cells: Different patterns of lymphokine secretion leads to different functional properties. Annu Rev Immunol 1989; 7: 145-73.
17. Mosmann TR, Subash S. The expanding universe of T-cell subsets: Th1,Th2 and more. Immunol Today 1996; 17: 138-46.
18. Nitta K, Akiba T, Kawashima A, Kimata N, Miwa N, Nishida E, Uchida K, Honda K, Yumura W, Nihei H. Characterization of Th1/Th2 profile in uremic patients. Nephron 2002; 91: 492-5.
19. Sester L, Sester M, Hauk M, Kaul H, Kohler H, Girndt M. T-cell activation follows Th1 rather Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 2000; 15: 1217-23.
20. Seder RA, Gazzinelli R, Sher A, Paul WE. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon γ production and diminish interleukin-4 inhibition of such priming. Proc Natl Acad Sci USA 1993; 90: 10188-92.
21. Hsing CH, Hsu CC, Chen WY, Chang LY, Hwang JC, Chang MS. Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol Dial Transplant 2007; 22: 2230-8.
22. Collet-Solberg PF, Cohen R The role of insulin-like growth factor binding proteins and the IGFBP proteases in modulation of IGF action. Endocrinol Metab Clin North Am 1996; 25: 519-26.
23. Roelfsema V, Clark RG. The growth hormone and insulinlike growth factor axis. Its manipulation for the benefit of growth disorders in renal failure. J Am Soc Nephrol 2001; 12: 1297-306.
24. Tönshoff B, Kiepe D, Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 2005; 20: 279-89.
25. Hirschberg R, Adler S. Insulin-like growth factor system and the kidney: physiology, pathophysiology, and therapeutic implications. Am J Kidney Dis 1998; 31: 901-19.
26. Richmond EJ, Uzri A, Rogol AD. The insulin-like growth factor system in kidney diseases. Nephron 2001; 89: 5-9.
27. Divino Filho JC, Hazel SJ, Furst P, Bergstrom J, Hall K. Glutamate concentration in plasma, erythrocyte and muscle in relation to plasma levels of insulin-like growth factor (IGF)-I, IGF binding protein-1 and insulin in patients on haemodialysis. J Endocrinol 1998; 156: 519-27.
28. Weinreich T, Zapf J, Schmidt-Gayk H, Ritzel H, Delling G, Reichel H. Insulin-like growth factor 1 and 2 serum concentrations in dialysis patients with secondary hyperparathyroidism and adynamic bone disease. Clin Nephrol 1999; 51: 27-33.
29. Powell DR, Lui F, Baker BK, Hinzt RL, Kale A, Suwanichkul A, Durham SK. Effect of chronic renal failure and growth hormone therapy on the insulin-like growth factors and their binding proteins. Pediatr Nephrol 2000; 14: 579-83.
30. Iglesias P, Díez JJ, Fernández-Reyes M J, Méndez J, Bajo MA, Aguilera A, Selgas R. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Clin Endocrinol (Oxf) 2004; 60: 741-9.
31. Rico-Bautista E, Flores-Morales A, Fernández-Pérez L. Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev 2006; 17: 431-9.
32. Kelley KW, Weigent DA, Kooijman R. Protein hormones and immunity. Brain Behav Immun 2007; 21: 384-92.
33. Castro AV, Caramori J, Barretti P, Baptistelli EE, Brandão A, Barim EM, Padovani CR, Aragon FF, Brandão-Neto J. Prolactin and zinc in dialysis patients. Biol Trace Elem Res 2002; 88: 1-7.
34. Clevenger CV, Sillman AL, Hanley-Hyde J, Prystowsky MB. Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology 1992; 130: 3261-2.
35. Viselli SM, Stanek EM, Mukherjee P, Hymer WC, Mastro AM. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 1991; 129: 983-90.
36. Breidthardt T, Frohn C, Luhm J, Kirchner H, Brand JM. Prolactin induces enhanced interferon gamma release in peripheral whole blood after stimulation with either PHA or LPS. Immunobiology 2002; 206: 424-31.
37. Matera. L, Mori M. Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells. Ann N Y Acad Sci 2000; 917: 505-13.
38. Meli R, Bentivoglio C, Nuzzo I, Mattace Raso G, Galdireo E, Galdiero M, Di Carlo R, Carratelli CR. Th1-Th2 response in hyperprolactinemic mice infected with Salmonella enterica serovar Typhimurium. Eur Cytokine Netw 2003; 14: 186-91.